This poster was presented at ISPOR EU, 2026. It compares patient characteristics and disease severity between site-based and direct-to-patient recruitment pathways in a real-world myasthenia gravis registry.
See here for more of our publications.
This poster was presented at ISPOR EU, 2026. It compares patient characteristics and disease severity between site-based and direct-to-patient recruitment pathways in a real-world myasthenia gravis registry.
See here for more of our publications.
Join us and receive white papers as they are published.